Shilpa Medicare Unit VII inspection ends with one procedural observation

Shilpa Medicare said the US Food and Drug Administration (USFDA) conducted a surveillance inspection at Unit VII of its Analytical Services Division in Hyderabad from 16 to 18 September 2026.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.